β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation.
Saved in:
| Title: | β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation. |
|---|---|
| Authors: | Mantuano, Paola1 (AUTHOR) paola.mantuano@uniba.it, Boccanegra, Brigida1 (AUTHOR) brigida.boccanegra@uniba.it, Conte, Elena1 (AUTHOR) elena.conte@uniba.it, De Bellis, Michela1 (AUTHOR) michela.debellis@uniba.it, Cirmi, Santa1 (AUTHOR) santa.cirmi@uniba.it, Sanarica, Francesca1 (AUTHOR) francesca.sanarica@uniba.it, Cappellari, Ornella1 (AUTHOR) ornella.cappellari@uniba.it, Arduino, Ilaria2 (AUTHOR) ilaria.arduino@uniba.it, Cutrignelli, Annalisa2 (AUTHOR) annalisa.cutrignelli@uniba.it, Lopedota, Angela Assunta2 (AUTHOR) angelaassunta.lopedota@uniba.it, Mele, Antonietta1 (AUTHOR) antonietta.mele@uniba.it, Denora, Nunzio2 (AUTHOR) nunzio.denora@uniba.it, De Luca, Annamaria1 (AUTHOR) annamaria.deluca@uniba.it |
| Source: | Biomolecules (2218-273X). Nov2021, Vol. 11 Issue 11, p1742. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
